Loading...
Conjugated Glypican 3 Rabbit mAb

C56189

Conjugated Glypican 3 Rabbit mAb

Conjugated Glypican 3 Rabbit mAb (catalogue number C56189) is a recombinant rabbit-derived conjugated primary antibody, reactive with Human samples. It targets Glypican-3 (GPC3): Cell surface proteoglycan. Supplied as 100ul at ₪1,627.49; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Conjugated Primary AntibodyHostRecombinant RabbitConjugateAF Dye
Host / source
Recombinant Rabbit
Reactivity
Human
Conjugate
AF Dye
UniProt ID
P51654
Gene
GPC3
Target organism
Homo sapiens
Catalogue number
C56189
Brand
LABO Scientific
Storage
Store at 4˚Cin dark for 6 months

Target background

Target: Glypican-3 (GPC3) · Homo sapiens

Cell surface proteoglycan. Negatively regulates the hedgehog signaling pathway when attached via the GPI-anchor to the cell surface by competing with the hedgehog receptor PTC1 for binding to hedgehog proteins. Binding to the hedgehog protein SHH triggers internalization of the complex by endocytosis and its subsequent lysosomal degradation. Positively regulates the canonical Wnt signaling pathway by binding to the Wnt receptor Frizzled and stimulating the binding of the Frizzled receptor to Wnt ligands. Positively regulates the non-canonical Wnt signaling pathway.

Subcellular location: Cell membrane

Tissue specificity: Detected in placenta (at protein level). Highly expressed in lung, liver and kidney

Sequence length: 580 aa · 65563 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at 4˚Cin dark for 6 months
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.